Tags
apoptosis
preclinical screening
hca
toxicity
cancer
cell line
tumor
cytotoxicity
braf
genetic correlation
resistant
kinase inhibitors
biomarkers
mek
cellular assays
in vitro
phenotypic drug discovery
anti-cancer
personalized medicine
preclinical
sensitivity
micronuclei
micronucleus
genotoxicity
genetic toxicity
steatosis
luminex
primary human cells
hepatotoxicity
phospholipidosis
primary cell model
mtor
akt
her2
erlotinib
expression
egfr
genotype
growth inhibition
biomarker
gene
proliferation
mrna
sanger
lapatinib
igfr
mutation
Mehr anzeigen
Präsentationen
(5)Tags
apoptosis
preclinical screening
hca
toxicity
cancer
cell line
tumor
cytotoxicity
braf
genetic correlation
resistant
kinase inhibitors
biomarkers
mek
cellular assays
in vitro
phenotypic drug discovery
anti-cancer
personalized medicine
preclinical
sensitivity
micronuclei
micronucleus
genotoxicity
genetic toxicity
steatosis
luminex
primary human cells
hepatotoxicity
phospholipidosis
primary cell model
mtor
akt
her2
erlotinib
expression
egfr
genotype
growth inhibition
biomarker
gene
proliferation
mrna
sanger
lapatinib
igfr
mutation
Mehr anzeigen